317 related articles for article (PubMed ID: 11139431)
1. In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist.
Drube S; Liebmann C
Br J Pharmacol; 2000 Dec; 131(8):1553-60. PubMed ID: 11139431
[TBL] [Abstract][Full Text] [Related]
2. Characterization of non-peptide bradykinin B2 receptor agonist (FR 190997) and antagonist (FR 173657).
Gobeil F; Montagne M; Inamura N; Regoli D
Immunopharmacology; 1999 Sep; 43(2-3):179-85. PubMed ID: 10596851
[TBL] [Abstract][Full Text] [Related]
3. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
[TBL] [Abstract][Full Text] [Related]
4. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
[TBL] [Abstract][Full Text] [Related]
5. Characterization of bradykinin receptors in a human osteoblastic cell line.
Brechter AB; Lerner UH
Regul Pept; 2002 Jan; 103(1):39-51. PubMed ID: 11738247
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: an in vitro study on human, rabbit and pig vascular B2 receptors.
Rizzi A; Rizzi C; Amadesi S; Calo' G; Varani K; Inamura N; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):361-7. PubMed ID: 10551272
[TBL] [Abstract][Full Text] [Related]
7. 5-hydroxytryptamine release from skin mast cells in vivo induced by peptide but not by nonpeptide ligands for bradykinin receptors.
Griesbacher T; Rainer I
Immunopharmacology; 1999 Sep; 43(2-3):195-201. PubMed ID: 10596853
[TBL] [Abstract][Full Text] [Related]
8. Kinin B1 and B2 receptors in pig vessels: characterization of two monoreceptor systems.
Rizzi A; Calò G; Amadesi S; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):662-70. PubMed ID: 9402047
[TBL] [Abstract][Full Text] [Related]
9. Tumour necrosis factor-alpha enhances bradykinin-induced signal transduction via activation of Ras/Raf/MEK/MAPK in canine tracheal smooth muscle cells.
Hsu YM; Chiu CT; Wang CC; Chien CS; Luo SF; Hsiao LD; Liang KY; Yang CM
Cell Signal; 2001 Sep; 13(9):633-43. PubMed ID: 11495721
[TBL] [Abstract][Full Text] [Related]
10. Characterization of bradykinin receptors in canine cultured corneal epithelial cells: pharmacological and functional studies.
Huang SC; Hsiao LD; Chien CS; Wang CC; Chiu CT; Tsai RJ; Yang CM
J Biomed Sci; 2002; 9(3):213-22. PubMed ID: 12065896
[TBL] [Abstract][Full Text] [Related]
11. Bradykinin B2 receptor-mediated proliferation via activation of the Ras/Raf/MEK/MAPK pathway in rat vascular smooth muscle cells.
Yang CM; Chien CS; Ma YH; Hsiao LD; Lin CH; Wu C
J Biomed Sci; 2003; 10(2):208-18. PubMed ID: 12595757
[TBL] [Abstract][Full Text] [Related]
12. A novel mitogenic signaling pathway of bradykinin in the human colon carcinoma cell line SW-480 involves sequential activation of a Gq/11 protein, phosphatidylinositol 3-kinase beta, and protein kinase Cepsilon.
Graness A; Adomeit A; Heinze R; Wetzker R; Liebmann C
J Biol Chem; 1998 Nov; 273(48):32016-22. PubMed ID: 9822674
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.
Asano M; Hatori C; Sawai H; Johki S; Inamura N; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Mizutani T; Oku T; Nakahara K
Br J Pharmacol; 1998 Jun; 124(3):441-6. PubMed ID: 9647466
[TBL] [Abstract][Full Text] [Related]
14. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin B(2) receptor-mediated mitogen-activated protein kinase activation in COS-7 cells requires dual signaling via both protein kinase C pathway and epidermal growth factor receptor transactivation.
Adomeit A; Graness A; Gross S; Seedorf K; Wetzker R; Liebmann C
Mol Cell Biol; 1999 Aug; 19(8):5289-97. PubMed ID: 10409720
[TBL] [Abstract][Full Text] [Related]
16. The expression of functionally-coupled B2-bradykinin receptors in human corneal epithelial cells and their pharmacological characterization with agonists and antagonists.
Wiernas TK; Griffin BW; Sharif NA
Br J Pharmacol; 1997 Jun; 121(4):649-56. PubMed ID: 9208130
[TBL] [Abstract][Full Text] [Related]
17. Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats.
Cloutier F; Ongali B; Campos MM; Thibault G; Neugebauer W; Couture R
Br J Pharmacol; 2004 May; 142(2):285-96. PubMed ID: 15066903
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological and functional characterization of the guinea-pig B2 bradykinin receptor stably expressed in CHO-K1 cell line.
Robert C; Pruneau D; Paquet JL
Br J Pharmacol; 2002 Jan; 135(2):462-8. PubMed ID: 11815382
[TBL] [Abstract][Full Text] [Related]
19. Study of the mechanisms involved in the bradykinin-induced contraction of the pig iris sphincter muscle in vitro.
El Sayah M; Calixto JB
Eur J Pharmacol; 2003 Jan; 458(1-2):175-81. PubMed ID: 12498923
[TBL] [Abstract][Full Text] [Related]
20. Characterization of bradykinin B(2) receptor antagonists in human and rat urinary bladder.
Meini S; Patacchini R; Giuliani S; Lazzeri M; Turini D; Maggi CA; Lecci A
Eur J Pharmacol; 2000 Jan; 388(2):177-82. PubMed ID: 10666510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
